University of Illinois at Chicago
Exemption #JDR442
Announcement of an Exempt Purchase
Award Info Published Thursday February 13, 2025
Therakos IncorporatedSt Louis, MO
- Amount: An estimated $4,000,000
- Terms: An estimated start date of 7/1/2025 through 6/30/2030
- Renewals: None
Summary
Vendors
1 total
0 BEP vendors
0 VBP vendors
0 Small businesses
The University award process may be delayed as this award goes through a state approval process.
First published Thursday, February 13, 2025
The University awarded a contract for INOmax (nitric oxide) therapeutic delivery systems.
INOmax (nitric oxide) therapeutic delivery systems required for the treatment of newborns with hypoxic respiratory failure. The therapeutic delivery systems consist of the following: mechanical ventilator, cylinder, calibration gases, injector modules, flowmeter kit, and tubing for the delivery of nitric oxide in purified form.
This purchase is exempt from the usual selection processes of the Procurement Code because the procurement expenditure is for medical supplies or medical at a university-operated health care center or dispensary that provides care, treatment, and medications for students, faculty and staff (30 ILCS 500 / 1-13(b-5)) The nitric oxide is needed for the therapeutic respiratory delivery systems. The FDA-approved systems are used to treat newborns with hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension.
For instructions on how to obtain a comprehensive purchase description, disclosure or contract forms, contact:
The State of Illinois has a policy to encourage prospective vendors to hire qualified veterans, minorities, females, persons with disabilities and ex-offenders.